Laura C Coates

Summary

Affiliation: University of Leeds
Country: UK

Publications

  1. doi request reprint Outcome Measures in Psoriatic Arthritis
    Laura Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA Electronic address
    Rheum Dis Clin North Am 41:699-710. 2015
  2. doi request reprint Treat to target in psoriatic arthritis-evidence, target, research agenda
    Laura C Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
    Curr Rheumatol Rep 17:517. 2015
  3. ncbi request reprint Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis
    E G Ferguson
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK
    Clin Exp Rheumatol 32:S-113-7. 2014
  4. doi request reprint Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK University of California, San Diego, California and Allergy, Immunology, and Rheumatology Division, University of Rochester Medical Center, Rochester, New York, USA L C Coates, MRCP, PhD, NIHR Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds A Kavanaugh, MD, University of California C T Ritchlin, MD, MPH, Allergy, Immunology, and Rheumatology Division, University of Rochester Medical Center Dr Kavanaugh and Dr Ritchlin contributed equally to this report
    J Rheumatol 41:2273-6. 2014
  5. doi request reprint GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York and the University of California at San Diego, California, USA L C Coates, MRCP, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds C T Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center A F Kavanaugh, MD, Professor of Medicine, University of California at San Diego
    J Rheumatol 41:1237-9. 2014
  6. doi request reprint Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease
    Laura C Coates
    University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
    Arthritis Rheum 65:1504-9. 2013
  7. pmc The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis
    Laura C Coates
    Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds LS7 4SA, UK
    BMC Musculoskelet Disord 14:101. 2013
  8. doi request reprint MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis
    Laura C Coates
    Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, UK
    Best Pract Res Clin Rheumatol 26:805-22. 2012
  9. doi request reprint Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting
    Laura C Coates
    University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK
    J Rheumatol 38:530-9. 2011
  10. doi request reprint GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting
    Laura C Coates
    Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds LS7 4SA, UK
    J Rheumatol 38:526-9. 2011

Collaborators

Detail Information

Publications28

  1. doi request reprint Outcome Measures in Psoriatic Arthritis
    Laura Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA Electronic address
    Rheum Dis Clin North Am 41:699-710. 2015
    ..New research into composite measures of psoriatic disease is summarized, including response measures and proposed cutoff points for disease activity. Finally, the key future issues in outcome measurement in PsA are addressed. ..
  2. doi request reprint Treat to target in psoriatic arthritis-evidence, target, research agenda
    Laura C Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
    Curr Rheumatol Rep 17:517. 2015
    ..To translate this into clinical practice in PsA, patient education and feasibility are key. Future research must address the optimal therapies to be used within a T2T framework which will need to take subtype of PsA into account. ..
  3. ncbi request reprint Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis
    E G Ferguson
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK
    Clin Exp Rheumatol 32:S-113-7. 2014
    ..Recently there have been advances in composite scores that include enthesitis and dactylitis to assess disease activity. These are currently being validated further and have not yet been tested in routine clinical practice. ..
  4. doi request reprint Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK University of California, San Diego, California and Allergy, Immunology, and Rheumatology Division, University of Rochester Medical Center, Rochester, New York, USA L C Coates, MRCP, PhD, NIHR Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds A Kavanaugh, MD, University of California C T Ritchlin, MD, MPH, Allergy, Immunology, and Rheumatology Division, University of Rochester Medical Center Dr Kavanaugh and Dr Ritchlin contributed equally to this report
    J Rheumatol 41:2273-6. 2014
    ....
  5. doi request reprint GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York and the University of California at San Diego, California, USA L C Coates, MRCP, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds C T Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center A F Kavanaugh, MD, Professor of Medicine, University of California at San Diego
    J Rheumatol 41:1237-9. 2014
    ..We also review the numerous discussions regarding how best to finalize and publish these new guidelines in 2014. ..
  6. doi request reprint Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease
    Laura C Coates
    University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
    Arthritis Rheum 65:1504-9. 2013
    ..To evaluate joint counts in patients with oligoarticular psoriatic arthritis (PsA) for their correlation with treatment decisions and to determine the proportion of patients in whom active disease was missed using reduced joint counts...
  7. pmc The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis
    Laura C Coates
    Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds LS7 4SA, UK
    BMC Musculoskelet Disord 14:101. 2013
    ....
  8. doi request reprint MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis
    Laura C Coates
    Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, UK
    Best Pract Res Clin Rheumatol 26:805-22. 2012
    ..All of these new techniques should aid our understanding of PsA and our ability to objectively measure response to therapy...
  9. doi request reprint Summary of the International Federation of Psoriasis Associations (IFPA) meeting: a report from the GRAPPA 2009 annual meeting
    Laura C Coates
    University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK
    J Rheumatol 38:530-9. 2011
    ..Key presentations at IFPA that GRAPPA members believed were highlights of that meeting are summarized here...
  10. doi request reprint GRAPPA Trainees Symposium 2009: a report from the GRAPPA 2009 annual meeting
    Laura C Coates
    Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds LS7 4SA, UK
    J Rheumatol 38:526-9. 2011
    ..Senior GRAPPA members also instructed the fellows on other composite scoring methods and on training videos and other GRAPPA projects to date. All of the posters and presentations from the Trainees Symposium are summarized herein...
  11. doi request reprint Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008
    Laura C Coates
    Academic Unit of Musculoskeletal Disease, University of Leeds, Leeds, UK
    J Rheumatol 37:448-52. 2010
    ..Further work is also required to examine the proposed common biomechanical basis between joint and skin, the mechanism of the resulting inflammation, and how these mechanisms differ from those seen in rheumatoid arthritis...
  12. doi request reprint Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
    Laura C Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Leeds NIHR Musculoskeletal Biomedical Research Unit, Leeds, UK
    Lancet 386:2489-98. 2015
    ..We aimed to assess the effect of tight control on early psoriatic arthritis using a treat-to-target approach...
  13. doi request reprint Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group
    Laura C Coates
    Section of Musculoskeletal Disease, University of Leeds, Leeds, UK
    J Rheumatol 38:1496-501. 2011
    ..Further work is required within the GRACE dataset to develop an optimal composite measure for PsA. Several proposals to date have shown preliminary validity according to the OMERACT filter...
  14. doi request reprint Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11
    Laura C Coates
    From the Division of Rheumatic and Musculoskeletal Disease, University of Leeds, UK Department of Rheumatology, St Vincent s University Hospital and Conway Institute, University College Dublin, Dublin, Ireland Seattle Rheumatology Associates, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA Division of Rheumatology, Department of Medicine, University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada Division of Immunology Rheumatology, Stanford University, Palo Alto, California Division of Rheumatology, Department of Medicine, Duke University Medical Center, Durham, and General Medicine Therapeutic Delivery Unit, Quintiles, Morrisville, North Carolina Department of Dermatology, University of Utah, Salt Lake City, Utah, USA Royal National Hospital for Rheumatic Diseases and University of Bath, Bath, UK
    J Rheumatol 41:782-91. 2014
    ..Future plans include qualitative work with patients to explore their experience of disease activity and statistical modeling to explore how each of the proposed measures will perform in different disease subgroups. ..
  15. pmc Is there subclinical synovitis in early psoriatic arthritis? A clinical comparison with gray-scale and power Doppler ultrasound
    Jane E Freeston
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
    Arthritis Care Res (Hoboken) 66:432-9. 2014
    ..The aim of this study was to compare clinical examination and ultrasound (US) findings in an early PsA cohort...
  16. doi request reprint Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort
    Laura C Coates
    University of Leeds, Chapel Allerton Hospital, Leeds, UK
    Arthritis Care Res (Hoboken) 62:970-6. 2010
    ..To establish the frequency and predictors of minimal disease activity in psoriatic arthritis (PsA) and to investigate the prognostic ability of minimal disease activity criteria to predict future joint damage...
  17. doi request reprint Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data
    Laura C Coates
    University of Leeds and Chapel Allerton Hospital, Leeds, UK
    Arthritis Care Res (Hoboken) 62:965-9. 2010
    ..The aim is to provide further validation of these criteria using data obtained in interventional trials with infliximab, a drug with proven efficacy in PsA...
  18. doi request reprint Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review
    Maria Laura Acosta Felquer
    From the Sección Reumatología, Servicio de Clinica Medica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Sección Reumatología, Servicio de Clinica Medica, Hospital Italiano de Buenos Aires Academic Unit of Rheumatology, Universidade Federal de Uberlandia, Uberlandia, MG, Brazil Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK Department of Rheumatology, St Vincent s University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland Department of Pharmacy and Pharmacology, University of Bath, Bath, UK Barking Havering and Redbridge University Hospitals, NHS Trust and Queens Mary s University of London, London, UK and Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA M L Acosta Felquer, MD, Seccion Reumatologia, Servicio de Clinica Medica, Hospital Italiano de Buenos Aires L C Coates, MRCP, College of Medicine
    J Rheumatol 41:2277-85. 2014
    ....
  19. ncbi request reprint Can biologic therapies be withdrawn or tapered in psoriatic arthritis?
    Anna R Moverley
    NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
    Clin Exp Rheumatol 31:S51-3. 2013
    ..In this way identifying which patients can successfully stop therapy will allow a more personalized approach to treatment decisions in PsA and will minimise risks and costs associated with ongoing therapy. ..
  20. doi request reprint Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis
    Laura C Coates
    University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK
    Arthritis Rheum 64:3150-5. 2012
    ....
  21. doi request reprint Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis
    Nick Barkham
    University of Leeds, UK
    Ann Rheum Dis 69:1926-8. 2010
    ..The aim of this study was to determine whether etanercept improves work instability as measured by the Ankylosing Spondylitis Work Instability Scale (AS-WIS)...
  22. doi request reprint Disease measurement--enthesitis, skin, nails, spine and dactylitis
    Laura C Coates
    Academic Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK
    Best Pract Res Clin Rheumatol 24:659-70. 2010
    ..Nail psoriasis is accurately measured by detailed scoring systems but these can be time-consuming...
  23. doi request reprint Treating to target in psoriatic arthritis: how to implement in clinical practice
    Laura C Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Ann Rheum Dis 75:640-3. 2016
    ..However, the question of the optimal measure to use and the practicalities of incorporating this into routine clinical practice remain problematic. ..
  24. doi request reprint Methotrexate Efficacy in the Tight Control in Psoriatic Arthritis Study
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals National Health Service NHS Trust, Leeds, UK L C Coates, NIHR Clinical Lecturer, MBChB, MRCP, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust P S Helliwell, Senior Lecturer, MA, MD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust
    J Rheumatol 43:356-61. 2016
    ..Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug in psoriatic arthritis, but there is conflicting evidence to support its efficacy...
  25. doi request reprint Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments
    Laura C Coates
    From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK L C Coates, MB, BS, MRCP, PhD, UK National Institute for Health Research Clinical Lecturer, University of Leeds P S Helliwell, MA, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds
    J Rheumatol 43:371-5. 2016
    ..To explore the relationship between minimal disease activity (MDA) and the low disease activity cutoffs of the Psoriatic ArthritiS Disease Activity Score (PASDAS) and the Composite Psoriatic Disease Activity Index (CPDAI)...
  26. doi request reprint Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools
    Laura C Coates
    Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK
    Arthritis Care Res (Hoboken) 66:1410-6. 2014
    ..This study aimed to develop new questionnaires encompassing the most discriminative questions from existing instruments...
  27. ncbi request reprint Improving recognition of psoriatic arthritis
    Philip G Conaghan
    Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit
    Practitioner 253:15-8, 2-3. 2009
    ..DMARDs are routinely used to treat all aspects of psoriatic disease, except spinal disease, and prescribing should be initiated by a specialist...
  28. pmc Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician
    Laura C Coates
    Section of Musculoskeletal Disease, University of Leeds, Leeds, UK
    Ther Adv Musculoskelet Dis 2:37-43. 2010
    ..Future studies and registry data will be able to assess whether TNF blockers have an additional role in controlling systemic inflammation and its associated cardiovascular risk...